Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer

Cancer Research

Volumn 59, Issue 2, 1999, Pages 377-381

  Utsumi, Toshiaki ^a   Yoshimura, Noriko ^a   Takeuchi, Shinji ^b   Ando, Jiro ^c   Maruta, Morito ^a   Maeda, Kotaro ^a   Harada, Nobuhiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Marumo Hospital   (Japan)

^c TOCHIGI CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL SULFATE; ESTRONE SULFATE; MESSENGER RNA; PRASTERONE; STERYL SULFATASE;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; ENZYME ACTIVITY; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ARYLSULFATASES; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, ESTROGEN; RNA, MESSENGER; STERYL-SULFATASE; SURVIVAL RATE;

EID: 0033555597     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Duncan, L., Purohit, A., Howanh, N. M., Potter, B. V., and Reed, M. J. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer. Cancer Res., 53: 298-303, 1993.
2. Purohit, A., Howarth, N. M., Potter, B. V., and Reed, M. J. Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: potential therapeutic agents in breast cancer. J. Steroid Biochem. Mol. Biol., 48: 523-527, 1994.
3. Howarth, N. M., Purohit, A., Reed, M. J., and Potter, B. V. Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem., 37: 219-221, 1994.
4. Purohit, A., Williams, G. J., Howarth, N. M., Potter, B. V., and Reed, M. J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry, 34: 11508-11514, 1995.
5. Li, P. K., Pillai, R., and Dibbelt, L. Estrone sulfate analogs as estrone sulfatase inhibitors. Steroids, 60: 299-306, 1995.
6. Selcer, K. W., Jagannathan, S., Rhodes, M. E., and Li, P. K. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives. J Steroid Biochem. Mol. Biol., 59: 83-91, 1996.
7. Purohit, A., Woo, L. W., Singh, A., Winterborn, C. J., Potter, B. V., and Reed, M. J. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor. Cancer Res., 56: 4950-4955, 1996.
8. Selcer, K. W., Hegde, P. V., and Li, P. K. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines. Cancer Res., 57: 702-707, 1997.
9. Santner, S. J., Feil, P. D., and Santen, R. J. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J. Clin. Endocrinol. Metab., 59: 29-33, 1984.
10. Pasqualini, J. R., Gelly, C., Nguyen, B. L., and Vella, C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem., 34: 155-163, 1989.
11. Evans, T. R., Rowlands, M. G., Law, M., and Coombes, R. C. Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. Br. J. Cancer. 69: 555-561, 1994.
12. Edery, M., Goussard, J., Dehennin, L., Scholler, R., Reiffsteck, J., and Drosdowsky, M. A. Endogenous oestradiol-17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur. J. Cancer. 17: 115-120, 1981.
13. Millington, D. S. Determination of hormonal steroid concentrations in biological extracts by high resolution mass fragmentography. J. Steroid Biochem., 6: 239-245, 1975.
14. van Landeghem, A. A., Poortman, J., Nabuurs, M., and Thijssen, J. H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res., 45: 2900-2906, 1985.
15. Vermeulen, A., Deslypere, J. P., Paridaens, R., Leclercq, G., Roy, F., and Heuson, J. C. Aromatase. 17δ-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer Clin. Oncol., 22: 515-525, 1986.
16. Utsumi, T., Harada, N., Maruta, M., and Takagi, Y. Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J. Clin. Endocrinol. Metab., 81: 2344-2349, 1996.
17. Noel, C. T., Reed, M. J., Jacobs, H. S., and James, V. H. The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J. Steroid Biochem., 14: 1101-1105, 1981.
18. Ruder, H. J., Loriaux, L., and Lipsett, M. B. Estrone sulfate: production rate and metabolism in man. J. Clin. Invest., 51: 1020-1033, 1972.
19. Santen, R. J., Santner, S., Davis, B., Veldhuis, J., Samojlik, E., and Ruby, E. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J. Clin. Endocrinol. Metab., 47: 1257-1265, 1978.
20. Reed, M. J., Lai, L. C., Owen, A. M., Singh, A., Coldham, N. G., Purohit, A., Ghilchik, M. W., Shaikh, N. A., and James, V. H. Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer. Cancer Res., 50: 193-196, 1990.
21. Svenstrup, B., Herrstedt, L. Brünner, N., Bennett, P., Wachmann, H., and Dombernowsky, P. Sex hormone levels in postmenopausal women with advanced metastatic breast cancer treated with CGS 16949A. Eur. J. Cancer, 30A: 1254-1258, 1994.
22. Dowsett, M., Smithers, D., Moore, J., Trunet, P. F., Coombes, R. C., Powles, T. J., Rubens, R., and Smith, I. E. Endocrine changes with the aromatase inhibitor fadrorole hydrochloride in breast cancer. Eur. J. Cancer. 30A: 1453-1458, 1994.
23. Johnston, S. R. Smith, I. E., Doody, D., Jacobs, S., Robertshaw, H., and Dowsett, M. Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer. Cancer Res., 54: 5875-5881, 1994.
24. Burns, G. R. Purification and partial characterization of arylsulphatase C from human placental microsomes. Biochim. Biophys. Acta, 759: 199-204, 1983.
25. Dibbelt, L., and Kuss, E. Human placental steryl-sulfatase. Enzyme purification, production of antisera, and immunoblotting reactions with normal and sulfatase-deficient placentas. Biol. Chem. Hoppe-Seyler, 367: 1223-1229, 1986.
26. Prost, O., and Adessi, G. L. Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies. J. Clin. Endocrinol. Metab., 56: 653-661, 1983.
27. MacIndoe, J. H., Woods, G., Jeffries, L., and Hinkhouse, M. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology, 123: 1281-1287, 1988.
28. Dao, T. L., and Libby, P. R. Conjugation of steroid hormones by normal and neoplastic tissues. J. Clin. Endocrinol. Metab., 28: 1431-1439, 1968.
29. Prost, O., Turrel, M. O., Dahan, N., Craveur, C., and Adessi, G. L. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma. Cancer Res., 44: 661-664, 1984.
30. Purohit, A., Dauvois, S., Parker, M. G., Potter, B. V. L., Williams, G. J., and Reed, M. J., The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells. J. Steroid Biochem. Mol. Biol., 50: 101-104, 1994.
31. Vignon, F., Terqui, M., Westley, B.. Derocq, D., and Rochefort, H. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology, 106: 1079-1086, 1980.
32. Pasqualini, J. R., Gelly, C., and Lecerf, F. Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res. Treat., 8: 233-240, 1986.
33. Santner, S. J., Ohlsson-Wilhelm, B., and Santen, R. J. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures. Int. J. Cancer. 54: 119-124, 1993.
34. Westley, B., and Rochefort, H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 20: 353-362, 1980.
35. Cavailles, V., Garcia, M., and Rochefort, H. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol. Endocrinol., 3: 552-558, 1989.
36. Poulin, R., and Labrie, F. Stimulation of cell proliferation and estrogenic response by adrenal C19-δ 5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res.. 46: 4933-4937, 1986.
37. Dauvois, S., and Labrie, F. Androstenedione and androst-5-ene-3β, 17β-diol stimulate DMBA-induced rat mammary tumors-role of aromatase. Breast Cancer Res. Treat.. 13: 61-69, 1989.
38. Poortman, J., Anderiesse, R., Agema, A., Donker, G. H., Schwarz, F., and Thijssen, J. H. H. Adrenal androgen secretion and metabolism in postmenopausal women. In: A. R. Genazzani, P. K Siiteri, and J. H. H. Thijssen (eds.). Adrenal Androgens, pp. 219-240, New York: Raven Press, 1980.
39. WHO. Histologic typing of breast tumours. In: International Histologic Classification of Tumours, No. 2. Geneva: WHO, 1981.
40. Bloom, H. J. G., and Richardson, W. W. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer. 11: 359-377, 1957.
41. McGuire, W. L., De La Garza, M., and Chamness, G. C. Evolution of estrogen receptor assays in human breast cancer tissue. Cancer Res., 37: 637-639, 1977.
42. Chirgwin, J. M., Przybla, A. E., MacDonald, K. J., and Utter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18: 5294-5299, 1979.
43. Kaplan, E. L., and Meier, P. Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
44. Cox, D. R. Regression models and life tables. J. R. Stat. Soc., 34: 187-220, 1972.
45. Tandon, A. K., Clark, G. M., Chamness, G. C., Chirgwin, J. M., and McGuire, W. L. Cathepsin D and prognosis in breast cancer. N. Engl. J. Med., 322: 297-302, 1990.
46. Evans, T. R., Rowlands, M. G., Luqmani, Y. A. Chander, S. K., and Coombes, R. C. Detection of breast cancer-associated estrone sulfatase in breast cancer biopsies and cell lines using polymerase chain reaction. J. Steroid Biochem. Mol. Biol., 46: 195-201, 1993.
47. Pasqualini, J. R., Chetrite, G., Nguyen, B. L., Maloche, C,. Delalonde, L., Talbi, M., Feinstein, M. C., Blacker, C., Botella, J., and Paris, J. Estrone sulfate-sulfatase and 17β-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone dependence to hormone independence. J. Steroid Biochem. Mol. Biol., 53: 407-412, 1995.